Minerva Neurosciences, Inc.
NERV
$7.85
$0.010.13%
NASDAQ
Corporate Info
Website
Phone Number
617 600 7373
Address
1500 District Avenue
Burlington, MA 01803
Burlington, MA 01803
Country
United States
Year Founded
2007
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
8
Business Description
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.